- 专利标题: Method of monomerisation of recombinant antibody molecules
-
申请号: US17078127申请日: 2020-10-23
-
公开(公告)号: US11786593B2公开(公告)日: 2023-10-17
- 发明人: Sam Philip Heywood , Gavin Barry Wild , Razwan Hanif , Christopher John Le Page
- 申请人: UCB BIOPHARMA SRL
- 申请人地址: BE Brussels
- 专利权人: UCB BIOPHARMA SRL
- 当前专利权人: UCB BIOPHARMA SRL
- 当前专利权人地址: BE Brussels
- 代理机构: SALIWANCHIK, LLOYD & EISENSCHENK
- 优先权: GB 06870 2015.04.22
- 主分类号: A61K39/395
- IPC分类号: A61K39/395 ; C07K1/113 ; C07K16/28 ; C07K16/18 ; C07K5/12 ; C07C323/12 ; C07C323/25
摘要:
The present invention provides method of increasing the percentage of monomer in a composition of recombinantly expressed antibody molecules characterised in that the antibody molecule comprises at least one Fv with specificity for an antigen of interest comprising one VH and one VL wherein said VH and VL are connected directly or indirectly via one or more linkers and are stabilised by a disulfide bond therebetween, said method comprises: a) a conversion step of treating the composition with a denaturant selected from urea and/or Guanidine hydrochloride; b) wherein step a) is performed in the presence of a reducing agent or after treatment with a reducing agent.
公开/授权文献
信息查询